BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1707359)

  • 1. [Pancreatitis associated with 5-aminosalicylic acid].
    Eckardt VF; Kanzler G; Rieder H; Ewe K
    Dtsch Med Wochenschr; 1991 Apr; 116(14):540-2. PubMed ID: 1707359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms].
    Schwörer H; Ramadori G
    Dtsch Med Wochenschr; 2000 Nov; 125(44):1328-30. PubMed ID: 11109415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].
    Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M
    Therapie; 1999; 54(1):41-8. PubMed ID: 10216421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperamylasemia, hyperlipasemia and acute pancreatitis in chronic inflammatory bowel diseases].
    Tromm A; Höltmann B; Hüppe D; Kuntz HD; Schwegler U; May B
    Leber Magen Darm; 1991 Jan; 21(1):15-6, 19-22. PubMed ID: 1709251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pancreatitis after long-term 5-aminosalicylic acid therapy.
    Fernández J; Sala M; Panés J; Feu F; Navarro S; Terés J
    Am J Gastroenterol; 1997 Dec; 92(12):2302-3. PubMed ID: 9399776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute pancreatitis--induced by 5-aminosalicylic acid or an extraintestinal manifestation of ulcerative colitis?].
    Petersen HH; Skovbjerg H
    Ugeskr Laeger; 1995 Sep; 157(39):5400-1. PubMed ID: 7483055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute pancreatitis due to 5-aminosalicylic acid].
    Romero Castro R; Jiménez Sáenz M; Pellicer Bautista FJ; Domínguez Palomo S; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 1991 Mar; 79(3):219-21. PubMed ID: 2043409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn's disease and ulcerative colitis.
    Bokemeyer B
    Z Gastroenterol; 2002 Jan; 40(1):5-10. PubMed ID: 11803494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatitis induced by disodium azodisalicylate.
    Poldermans D; van Blankenstein M
    Am J Gastroenterol; 1988 May; 83(5):578-80. PubMed ID: 2452567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amylase and lipase in the evaluation of acute abdominal pain.
    Chase CW; Barker DE; Russell WL; Burns RP
    Am Surg; 1996 Dec; 62(12):1028-33. PubMed ID: 8955242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pancreatitis during oral 5-aminosalicylic acid therapy.
    Fiorentini MT; Fracchia M; Galatola G; Barlotta A; de la Pierre M
    Dig Dis Sci; 1990 Sep; 35(9):1180-2. PubMed ID: 2390934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis.
    Gumaste VV; Roditis N; Mehta D; Dave PB
    Am J Gastroenterol; 1993 Dec; 88(12):2051-5. PubMed ID: 7504396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
    Maier K; Frühmorgen P; Bode JC; Heller T; von Gaisberg U; Klotz U
    Dtsch Med Wochenschr; 1985 Mar; 110(10):363-8. PubMed ID: 2857633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pericardial effusion during the therapy of Crohn's disease with 5-aminosalicylic acid].
    Weber P; Becker EW; Jenss H
    Dtsch Med Wochenschr; 1988 Nov; 113(46):1806-7. PubMed ID: 3191853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
    Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
    Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K; Fischer C; Klotz U; Heinkel K
    Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].
    Kim KH; Kim TN; Jang BI
    Korean J Gastroenterol; 2007 Dec; 50(6):379-83. PubMed ID: 18159175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.